drugset / Trial / NCT03513250

Efficacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.

NCT03513250

Completed 92 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

a prospective, randomized, placebo-controlled study will be conducted to investigate whether hyoscine-n-butylbromide has preventive effects on early postoperative CRBD in patients with urinary catheters who will undergo elective cesarean sections.

Timeline

Start
2018-05-30
Primary completion
2020-07-01
Completion
2020-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyoscine butylbromide Unknown 20 mg Intravenous

Indications